Nicholas A.J. Botwood

Head of R&D, CMO, Syndax Pharmaceuticals Inc

Bought, 12 months

$0.0M

Sold, 12 months

$1.2M

Companies

Latest trade

Jun 12, 2026

Companies

Syndax Pharmaceuticals IncHead of R&D, CMO −$1.2M

Trades

SNDX Sold 31,235 shares at $18.14 · planned $0.6M Jun 12

SNDX Sold 34,280 shares at $18.00 · planned $0.6M Jun 11

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.